Journal of Dairy Research, Page 1 to 6. doi:10.1017/S0022029913000010
© Proprietors of Journal of Dairy Research 2013
1
Tissue-type plasminogen activator and plasminogen embedded in casein rule its degradation under physiological situations: manipulation with casein hydrolysate Nissim Silanikove1*, Fira Shapiro1, Uzi Merin2 and Gabriel Leitner3 1
Biology of Lactation Laboratory, Institute of Animal Science, Agricultural Research Organization, The Volcani Center, P.O. Box 6, Bet Dagan 50250, Israel 2 Department of Food Quality and Safety, Institute of Postharvest and Food Sciences, A.R.O., The Volcani Center, P.O. Box. 6, Bet Dagan 50250, Israel 3 National Mastitis Reference Center, Kimron Veterinary Institute, P.O. Box 12, Bet Dagan 50250, Israel Received 27 November 2012; accepted for publication 16 January 2013
The aims of this study were to test the assumption that tissue-type plasminogen activator (t-PA) and plasminogen (PG) are closely associated with the casein micelle and form a functional complex that rules casein degradation. This assumption was essentially verified for bovine milk under conditions wherein the plasmin system was activated by treatment with casein hydrolysate. It was also shown that urokinase-type PA (u-PA), the second type of plasminogen activator present in milk, was not involved in casein degradation. In agreement with previous studies, we show that treatment with casein hydrolysate precipitously reduced mammary secretion, disrupted the tight junction integrity (increase in Na+ and decrease in K+ concentrations), induced hydrolysis of casein, and activated various elements of the innate and acquired immune system. In the present study, we have identified t-PA as the principal PA, which is responsible for the conversion of PG to plasmin. It was found that t-PA and plasminogen are present in freshly secreted milk (less than 10 min from its secretion), suggesting that they are secreted as a complex by the mammary gland epithelial cells. Further research is needed to provide the direct evidence to verify this concept. Keywords: t-PA, u-PA, plasminogen, plasmin, casein, milk, bovine.
Milk secretion rate in various mammals is tightly associated with the fluctuating nutritional demands of offspring, and mammary gland (MG) development stages are closely related to the nurse’s reproduction cycles (Oftedal, 1984; Wilde & Peaker, 1990). Regulation of day-to-day variation in milk secretion (Wilde & Peaker, 1990; Daly et al. 1993) and induction of MG involution (Silanikove et al. 2006) are ruled by a milk-borne negative feedback (MBNF) system. The plasminogen activator (PA)-plasminogen (PG)-plasmin (PL) enzymic system is ubiquitously expressed in the milk of humans (Heegaard et al. 1997), rodents (Tonner et al. 2000) and ruminants (Silanikove et al. 2006), and was found to be associated with regulation of milk secretion in both cows and goats (Silanikove et al. 2000, 2009) and activation of involution in rodents (Tonner et al. 2000), goats (Shamay et al. 2002) and cows (Politis, 1996; Shamay et al. 2003; Silanikove et al. 2005b).
*For correspondence; e-mail:
[email protected]
As in other body tissues, PL is presented in milk mainly in its inactive zymogen form PG, whose conversion to PL is modulated by PAs (Politis, 1996). The two types of PAs that exist in mammals systemic fluids, urokinase-type PA (u-PA) and tissue-type PA (t-PA) are also presented in milk (Heegaard et al. 1994b; White et al. 1995; Politis, 1996; Tonner et al. 2000). In milk, PL, PG and t-PA are closely associated with the casein micelles, whereas u-PA is associated with neutrophils in close association with its specific receptor (Heegaard et al. 1994b; Politis, 1996). The MBNF system associated with regulation of milk secretion was shown to comprise the PA-PG-PL system that specifically forms a β-casein (CN) fragment (f) (1–28) from β-CN, which in return serves as the negative control signal by closing potassium channels on the apical membrane of the epithelial cells of the MG (Silanikove et al. 2000, 2009). Down-regulation of these channels induces undefined inwardly directed cellular signals that inhibit milk secretion. Interestingly, a further activation of the PA-PG-PL system, which was coupled to more extensive degradation of casein
2
N Silanikove and others
induced involution of the MG in lactating goats and cows and forcefully activated the innate immune system (Shamay et al. 2002, 2003; Silanikove et al. 2005b). Based on these findings, a casein hydrolysate (CNH) preparation was developed to reduce the suffering from MG engorgement associated with abrupt cessation of milking (the conventional procedure to induce involution in modern dairy cows) (Leitner et al. 2007) and to treat and prevent common clinical and subclinical infections of the udder in dairy cows (Silanikove et al. 2005a; Leitner et al. 2011a, 2012). It was also found that CN-derived peptides induced by PL activity inhibit milk clotting (Merin et al. 2008; Fleminger et al. 2011, 2012), which is important during mastitis and milk stasis in preventing uncontrolled inflammation (Leitner et al. 2011b). There is convincing evidence that under physiological situations, t-PA is the main factor involved in casein hydrolysis (Heegaard et al. 1994a; Politis, 1996; Tonner et al. 2000). However, the picture remains unclear because: firstly, there are lots of data showing that u-PA is a major factor involved in CN hydrolysis in stored milk (Ismail & Nielsen, 2010); and secondly, the increase of u-PA secretion by MG epithelial cells under inflammation is claimed to be responsible for CN degradation in goats’ milk under mastitis (Heegaard et al. 1994a; Politis, 1996; Weng et al. 2006). The association of t-PA with the CN micelles suggests that it constitutes a pivotal component of the MBNF system; however, as noted above, evidence for the involvement of u-PA confronts this assumption. The ability of CNH to up-regulate the PL system activity in a manner that imitates in an accelerated manner the events associated with MG involution stage I (Shamay et al. 2002; Silanikove et al. 2005b) represent an opportunity to test the assumption regarding the pivotal role of t-PA in CN degradation under relevant physiological situations. The aims of the present study were: firstly, to test the assumption that t-PA and PG embedded within casein micelles form a functional complex that rules casein hydrolysis, by analysing the distribution of the PL system in different fractions of bovine milk in control and in response to CNH treatment; secondly, to test the assumption that t-PA, PG and CN micelle are secreted by MG cells as functional units by verifying the presence of t-PA and PLG in CN micelles in freshly secreted milk; and thirdly, to exclude the role of u-PA in CN hydrolysis under the experimental conditions.
Materials and methods H-D-Norleucyl-hexahydrotyrosol-lysine-pnitroanilide diacetate [Spectrozyme PL (SpecPL)], bovine PG, and cyanogens bromide fibrinogen digest (FIBGN) were purchased from American Diagnostica (Greenwich CT, USA). N-methylsulphonyl-D-Phe-Gly-Arg-4-nitroanilide acetate substrate was obtained from Boehringer Mannheim (Chromozym t-PA; UK, East Sussex, UK). Polyclonal rabbit
anti-human t-PA IgG was obtained from Oxford Biomedical Research (Oxford, UK) and plasminogen activator inhibitor-1 (PAI-1), was from Calbiochem (USA). Other mentioned chemicals were purchased from Sigma (Rheovot, Israel). Ethical considerations All protocols were approved by the Institutional Animal Care Committee of the Agricultural Research Organization, which is the legitimate body for such authorizations in Israel. Experiment 1 Six Israeli Holstein heifers with low leucocyte content, as indicated by low somatic cell count (< 70 000 cells/ml) and no bacterial finding according to preliminary analysis (Leitner et al. 2011a), milk yield *36 litre/d, in their second to third lactation were used. Two MGs, one front and one rear quarter, were infused with sterile saline solution while the other two counter glands were infused with casein hydrolysate (CNH). The experiment was carried out during November under natural lighting regimen, with typical noon temperatures of 24 °C and night temperatures of 12 °C, which is within the thermoneutral zone of cows (Silanikove, 2000). The cows were milked thrice daily (5·30, 12·30 and 21·30) and milk yield and exact milking times were individually recorded automatically (Leitner et al. 2012). All experimental procedures were carried out during the noon milking. Milk samples (100 ml) were taken from every gland of each cow at 24, 0, + 24 h relative to treatment with saline solution and CNH, where 0 h refers to day of infusion. Milk samples on day 0 were taken prior to the infusion. On day 0, a dose of 10 ml of CNH (Leitner et al. 2011a), with a peptide concentration of *7 mg/ml was infused into each treated gland with a special applicator following careful sterile cleaning of the teat. The control glands of the cows in the first group were infused with 10 ml of sterile saline. Milk was discarded for 3 d following the infusion. Analytical procedures. One set of samples (10 ml) was sent to the central laboratory for the determination of total protein, fat, lactose and somatic cell count (Silanikove et al. 2009). A second set of milk samples (2 × 10 ml) were defatted at 4 °C (Silanikove & Shapiro, 2007) and analysed according to previously described procedures for: concentration of lactose, protein, fat, casein, whey protein, proteose peptones, lactoferrin, albumin, Na+ and K+ and the activity of xanthine oxidase, lactoperoxidase, and the concentration of nitrite (by the DAN reagent), nitrate (by the Griess reaction) and uric acid (Silanikove et al. 2005b). A sub-set of skim milk was ultracentrifuged and clear milk serum (whey) devoid of membranous particles and casein micelle pellet were separated (Silanikove & Shapiro, 2007).
Association of t-PA and plasminogen with casein
3
Table 1. Effect of treatment with casein hydrolysate (CNH) on milk yield (on a single gland level) and skim milk composition of protein, casein degradation products (proteose peptones), Na, K and components of the immune system in pre-treated, control and treated glands (mean ± SD) Pre-treated†
Control†
a
Milk yield, litre/d Lactose, mM Na+, mM K+, mM Total protein, mg/ml Casein, mg/ml Whey protein, mg/ml Proteose peptones, μg/ml IgG, μg/ml Lactoferrin, μg/ml Albumin, μg/ml Uric acid, μM nitrite, μM nitrate, μM Lactoperoxidase, unit/ml Xanthine oxidase, unit/ml (Somatic cell count × 10 3)/ml
Treated† a
8·2 ± 1·4 142 ± 6·2a 29·1 ± 4·6a 33·1 ± 4·8a 32·8 ± 2·6a 24·9 ± 2·8a 7·9 ± 2·0a 472 ± 31·2a 307·9 ± 25·2a 200·1 ± 23·8a 255·6 ± 18·5a 35·2 ± 6·6a 0·8 ± 0·3a 27·1 ± 5·1a 3·1 ± 1·1a 12·6 ± 3·3a 8·2 ± 0 9a
8·5 ± 1·5 148 ± 5·5a 26·2 ± 4·4a 37·2 ± 5·1a 32·4 ± 2·5a 24·6 ± 2·7a 7·8 ± 1·9a 465 ± 29·5a 200·5 ± 19·9a 175·2 ± 19·1a 127·0 ± 17·9a 34·7 ± 5·9 a 0·6 ± 0·2 a 25·1 ± 4·7 a 2·5 ± 0·5 a 11·6 ± 2·9 a 7·5 ± 0·8 a
1·5 ± 0·9b 19·2 ± 3·5b 110·0 ± 8·5b 8·2 ± 1·9b 39·8 ± 3·1b 25·8 ± 3·4b 14·0 ± 2·2b 1037 ± 37·5b 998·5 ± 31·3b 1425 ± 41·3b 600·5 ± 24·9b 75·2 ± 8·7b 8·1 ± 1·1b 145·6 ± 9·9b 14·7 ± 1·3b 70·9 ± 5·7b 105·0 ± 12·1b
† Results from Experiment 1 a, b Values marked by different superscript are significantly different, at least P < 0·01
Table 2. Effect of casein hydrolysate (CNH) treatments on the distribution of plasminogen activator (PA) activity (unit/ml†) in milk fractions (mean ± SD) Glands Plasminogen activator (PA) Casein micelle Milk serum Milk somatic cells
Pre-treated‡ d
115·1 ± 5·8 5·5 ± 2·2a b.d
Control‡
Treated‡ d
118·0 ± 6·6 4·5 ± 2·5a b.d
463·2 ± 11·7e 11·2 ± 3·7b 91·1 ± 9·9c
† Unit/ml: using dilution and protein content, activity of PA was calculated to be based per ml of reconstituted raw milk ‡ Results from Experiment 1 b.d, below detection level a,b,c,d,e Values marked by different superscript are significantly different, at least P < 0·01
A third set of samples (70 ml) was used to isolate somatic cells from milk. The samples were centrifuged at 2000 g at 4 °C for 30 min; then the fatty fraction and supernatant were removed. Cells from the bottom layer were suspended in 500 μl PBS (pH 7·4) containing 0·02% NaN3 and centrifuged twice (400 g at 4 °C for 15 min) to concentrate cells. After separation, the cells were lysed by at least 3 freeze–thaw cycles. Activities of PL, PG, PA, t-PA and u-PA were determined in the whey and in the re-dissolved casein micelle pellets and isolated somatic cells (Ismail et al. 2006). Whey, casein micelle pellets (1 mg/ml), cell lysates and other reagents were dissolved and diluted in 0·05 modified Tris buffer (MTB) composed of 0·05 m-Tris, 0·1 m-NaCl, 0·01% Tween 80, pH 7·6. The actual amount of proteins in the reaction mixtures was determined by the Bradford method. The types of PA present in the CN micelles were further established as follows: (i) PA activity was determined in the
presence of fibrinogen fractions (FIBGN; 16·2 μg/ml), with and without 4 mM of amiloride (Heegaard et al. 1994b) (ii) Polyclonal rabbit anti-human t-PA IgG was included to a final concentration of 0·1 mg/ml in the reaction mixture for direct determination of t-PA activity, and (iii) the effects of PAI-1 at a final concentration of 500 ng/ml was determined in the CN micelles under the conditions of the direct t-PA analysis (Sorrell et al. 2006). Experiment 2 Milk (*50 ml per cow) was obtained from udders of six Israeli-Holstein cows of milk yield *40 litre/d. The sample from each cow was taken from a mixed yield of a bacteriafree (see Experiment 1) single udder, and was designated as mature milk. Fresh milk samples (milk secreted within 10 min after being secreted) were obtained with the use of oxytocin injections (Silanikove et al. 2007) and transported to a nearby laboratory, where they arrived at a temperature of 6–10 °C, and were analysed within less than 20 min for their content of xanthine + hypoxanthine (Silanikove et al. 2007). Fresh milk was fractionated to obtained whey, CN micelle and somatic cells and these fractions were analysed for the content of t-PA, u-PA, PG and PL as described for Experiment 1. Statistical analysis Results of Experiment 1 were analysed by using repeatedmeasures analysis as described previously for the effects of treatment, day, and treatment × day interactions (Shamay et al. 2003). Effects of parity and of days in milk were not significant (P > 0·25) and therefore were not included in the analyses presented here.
N Silanikove and others
4
Table 3. Effect of casein hydrolysate (CNH) treatments on the activities of the plasminogen activator (PA)-plasminogen (PG)-plasmin (PL) (unit/ ml†) in isolated casein micelles in pre-treated, control, freshly secreted milk and treated gland (mean ± SD) Pre-treated‡
Freshly secreted§
a
PA t-PA Plasminogen Plasmin Plasminogen + plasmin Plasminogen/plasmin
a
114·7 ± 5·9 110·0 ± 5·7a 38·1 ± 4·9a 5·2 ± 2·8a 43·1 ± 6·8a 7·3 ± 1·5a
115·1 ± 5·8 109·5 ± 5·5a 37·5 ± 3·8a 5·1 ± 1·9a 42·6 ± 6·1a 8·4 ± 1·1a
Control‡
Treated‡ a
118·0 ± 6·6 110·5 ± 6·3a 40·4 ± 4·3a 5·3 ± 3·8a 42·7 ± 5·8a 8·6 ± 2·1a
463·2 ± 11·7b 461. 2 ± 10·7b 6·1 ± 3·8b 42·4 ± 5·2b 48·5 ± 7·3a 1·1 ± 0·5b
† Unit/ml: using dilution and protein content, activities of PA, PLG and PL were calculated to be based per ml of reconstituted raw milk ‡ Results from Experiment 1 § Results from Experiment 2 a,b Values marked by different superscript are significantly different, at least P < 0·01
Table 4. Effect of amiloride, anti-U-PA, PA-I and fibrin on plasminogen activator (PA) activity (unit/ml†) in isolated casein micelles and isolated somatic cells (mean ± SD) Treatments Pre-treated‡ Amiloride Anti u-PA Anti t-PA Fibrin PA-I
Casein micelle‡ a
120·2 ± 5·8 118 ± 6·1a 115 ± 7·1a 15·7 ± 4·9b 185 ± 7·9b 25·0 ± 5·5b
Somatic cells‡ 10·5 ± 1·1a 1·9 ± 0·9b 0·9 ± 1·1b 10·4 ± 1·3a 10·5 ± 1·5a 10·3 ± 1·4a
† Unit/ml: using dilution and protein content, activity of PA was calculated to be based per ml of reconstituted raw milk ‡ Milk from pre-treated gland (6 cows) was used to isolate casein micelles and somatic cells a,b Values marked by different superscript are significantly different from the pre-treated values by paired t test analysis, at least P < 0·01
Results Treating MG with CNH induced dramatic changes in the secretion and composition of milk in the treated glands, whereas no significant changes were recorded in the control glands (Table 1). Milk yield fell 5·5-fold in comparison with pre-treated or control levels, and lactose concentration drooped 7·7-fold, so that lactose secretion was reduced by *42-fold. Na+ concentration increased *4-fold whereas K+ concentration decreased *4-fold, so that their level in milk of treated glands resembled the expected level of Na+ and K+ in blood plasma. Protein concentration increased in the skim milk of treated glands by *22%, which could be related to increase of 78% in whey protein concentration. This was particularly associated with a dramatic increase in the concentration of proteose peptones (CN hydrolysis peptides), and soluble components of the acquired (IgG), and innate (lactoferrin, albumin, lactoperoxidase, xanthine oxidase) immune system and related metabolites (uric acid, nitrite and nitrate). CNH treatment was also associated with *14-fold increase in the treated glands in the count of somatic cells, which were composed mainly of leucocytes. Most of the PA activity in pre-treated and control glands was associated with the CN micelles and only a minority was found in milk serum and somatic cells (Table 2).
CNH treatment induced increase in PA activity in CN micelle and somatic cells. However, the activity of PA in CN micelles per ml milk was 4-fold higher than in somatic cells. No PG activity could be detected in milk serum or in the somatic cells (data not shown in a table). Activity of t-PA in CN micelles: pre-treated, control and treated glands accounted for the vast majority of PA activity (Table 3). CNH treatment induced dramatic reduction in PG activity without change in total PG + PL activity. Thus, the large increase in PL activity in the CNH-treated glands can be related to conversion of PG to PL and was associated with dramatic reduction in PG to PL ratio (Table 3). PA activity was measured with the following additions in CN micelles and somatic cells (Table 4). Amiloride and antiu-PA antibody did not affect PA activity in CN micelles, but reduced it in somatic cells. PAI-1 and anti t-PA antibody dramatically reduced PA activity in CN micelles, but not in somatic cells. Addition of fibrin increased PA activity in CN micelles, but not on somatic cells. Concentration of xanthine + hypoxanthine in milk defined as freshly secreted was 38·5 ± 5 μM. On the other hand, no xanthine + hypoxanthine could be detected in milk defined as mature milk, or in freshly secreted milk stored at 37 °C for 30 min (data not shown in a table). We can conclude that freshly secreted milk represent milk that was sampled within 10 min or less after being secreted (Silanikove et al. 2007). The content of t-PA, PG and PL in freshly secreted milk was found to be similar to those found in milk from pre-treated and control glands (Table 4).
Discussion It is well established that amiloride affects u-PA but not t-PA that PA-1 affects t-PA but not u-PA and that fibrin accelerates t-PA activity but not u-PA activity (Heegaard et al. 1994b; White et al. 1995; Politis, 1996; Sorrell et al. 2006; Ismail & Nielsen, 2010). Based on that, it can be concluded that under physiological conditions, t-PA in milk is vastly associated with the CN micelles, whereas, u-PA cannot be traced in the micelles. This conclusion is further supported by the interaction with respective antibodies to t-PA and
Association of t-PA and plasminogen with casein u-PA. As mentioned, this conclusion is also consistent with some previous reports (Heegaard et al. 1994a; Politis, 1996; Tonner et al. 2000). However, what is unique to the present study is that the large increase in t-PA activity was induced by CNH. In previous studies, it was shown that CNH induces accelerated MG involution, which was associated with intense activation of the MG immune system (Shamay et al. 2002; Silanikove et al. 2005b). This conclusion is supported by the present results, which demonstrate that the treatment with CNH precipitously reduced mammary secretion, disrupted the tight junction (increase in Na+ and decrease in K+ concentrations), induced hydrolysis of CN, and activated various elements of the innate and acquired immune system. These aspects were considered in detail in previous publications (Shamay et al. 2002; Silanikove et al. 2005b, 2006) and therefore were not considered here in detail. However, the data are consistent with the theory that the PL system plays a key role in inducing MG involution by degradation of CN micelles and liberating or inducing the formation of active components that in turn affect MG epithelial cells to commit involution. In the present study, we have identified t-PA as the principal PA, which is responsible for the conversion of PG to PL. In accordance with previous studies, PG was found to be closely associated with the casein micelles (Politis, 1996; Weng et al. 2006). However, perhaps the most novel finding of this study, namely, the presence of t-PA and PG in the CN micelles of freshly secreted milk provides new insight into the setting of PL-casein interactions. It was already demonstrated that t-PA is produced and secreted by MG cells (Politis, 1996; Zavizion et al. 1996). Thus, the close presence of t-PA and CN micelles should not be surprising as they both share the same excretory pathway through secretory vesicles released from the Golgi apparatus and because t-PA has high affinity to the CN micelles (Silanikove et al. 2005a; Ismail & Nielsen, 2010). Following early suggestion (Politis, 1996), PG is generally considered to leak to milk from blood plasma. Though, to the best of our knowledge, there is no evidence that supports this notion. The presence of PG in the CN micelles of fresh milk and its lack of presence in the whey of fresh milk suggest that it is secreted into milk through the secretory vesicles route embedded within the CN micelles along with its activator, t-PA, and based on the results of Sorrel et al. (2006), most likely along with PA-1 because it secreted by MG cells (Zavizion et al. 1996). In a close remark, we would like to relate to the following example as further support for this assumption. The presence of substances such as albumin and PG in milk in animals whose mammary gland epithelial tight junction is intact is a conundrum in that they are able to prevent the passage of ions, such as Na+ and K+. It has been shown that albumin, which also conventionally has been considered to derive in milk from blood plasma, is produced and secreted by mammary gland cells of bovine as a component of the innate immune system (Shamay et al. 2004). In view of the impressive synthesizing repertoire of the mammary epithelial cells, it should not be surprising to find that they are
5
capable of synthesizing PG. However, obviously, further research applying molecular and cell biology techniques to mammary epithelial cells is needed to support this assumption. The close association between PL, t-PA, PA-1 and CN suggests that these components serve as functional complexes that regulate the liberation of active components from the CN micelle. Such an arrangement allows effective fine tuning of the CN micelle degradation process: (i) it allows the complex to function as a time machine; milk stasis will result in longest exposure and thus higher degradation, and (ii) it allows fast responsive reaction to relevant systemic hormonal effects, which either attenuate or stimulate CN hydrolysis (Silanikove et al. 2006). Localization of u-PA with somatic cells and lack of u-PA activity in milk serum is consistent with previous reports (Heegaard et al. 1994a, b; Politis, 1996). In more detailed studies, it was demonstrated that milk u-PA is bound mostly to u-PA receptors on polymorphonuclear cells. Recently it was shown that MG cells respond to lipopolysacharide challenge (pro-inflammatory stress) by increasing the expression of u-PA. The physiological role of u-PA was attributed to its ability to induce basal membrane degradation that helps to induce inflow of polymorphonuclear cells to injured or infected tissue (Theodorou et al. 2009; Baldi et al. 2012). According to the present findings, the reported correlation between increased u-PA activity and CN hydrolysis during mastitis (Weng et al. 2006), merely reflects the fact that they respond similarly to the inflammatory stress. Our results and others (Heegaard et al. 1994a, b; White et al. 1995; Politis, 1996) clearly indicate that there is no direct relation between u-PA activity and CN hydrolysis in raw milk during inflammation. The substantial evidence for the major role of u-PA in CN degradation in stored milk may be explained by the dissociation of u-PA from its receptor on leucocytes and the tendency of u-PA to form interaction with CN. There are many reports that show that heat treatment, such as that applied to milk during pasteurization, inactivates PAI-1 and increase the association between u-PA and CN (Ismail & Nielsen, 2010).
References Baldi A, Pecorini C, Rebucci R, Saccone F, Cheli F, Miranda-Ribera A, Lecchi C & Ceciliani F 2012 Effect of Escherichia coli lipopolysaccharide on u-PA activity and u-PA and u-PAR RNA expression in a bovine mammary epithelial cell line. Research in Veterinary Science 93 758–762 Daly SEJ, Owens RA & Hartmann PE 1993 The short-term synthesis and infant-regulated removal of milk in lactating women. Experimental Physiology 78 209–220 Fleminger G, Heftsi R, Merin U, Silanikove N & Leitner G 2011 Chemical and structural characterization of bacterially-derived casein peptides that impair milk clotting. International Dairy Journal 21 914–920 Fleminger G, Heftsi R, Merin U, Silanikove N & Leitner G 2013 Low molecular mass peptides generated by hydrolysis of casein impair rennet coagulation of milk. International Dairy Journal 30 74–78 Heegaard CW, Christensen T, Rasmussen MD, Benfeldt C, Jensen NE, Sejrsen K, Petersen TE & Andersen PA 1994a Plasminogen activators in
6
N Silanikove and others
bovine-milk during mastitis, an inflammatory disease. Fibrinolysis 8 22–30 Heegaard CW, Rasmussen LK & Andresen PA 1994b The plasminogen activation system in bovine milk: differential localization of tissue-type plasminogen activator and urokinase in milk fractions is caused by binding to casein and urokinase receptor. Biochimica et Biophysica Acta – Molecular Cell Research 1222 45–55 Heegaard CW, Larsen LB, Rasmussen LK, Hojberg KE, Petersen TE & Andersen PA 1997 Plasminogen activation system in human milk. Journal of Pediatric Gastroenterology and Nutrition 25 159–166 Ismail B & Nielsen SS 2010 Invited review: plasmin protease in milk: current knowledge and relevance to dairy industry. Journal of Dairy Science 93 4999–5009 Ismail B, Choi LH, Were LM & Nielsen SS 2006 Activity and nature of plasminogen activators associated with the casein micelle. Journal of Dairy Science 89 3285–3295 Leitner G, Jacoby S, Maltz E & Silanikove N 2007 Casein hydrolyzate intramammary treatment improves the comfort behavior of cows induced into dry-off. Livestock Science 110 292–297 Leitner G, Jacoby S & Silanikove N 2011a An evaluation of casein hydrolyzate in combination with antibiotic for bacterial cure and subsequent increase in milk yield in dairy cows. BMC Veterinary Research 7 3 Leitner G, Merin U & Silanikove N 2011b Effects of glandular bacterial infection and stage of lactation on milk clotting parameters: comparison among cows, goats and sheep. International Dairy Journal 21 279–285 Leitner G, Koren O, Jacoby S, Merin U & Silanikove N 2012 Options for handling chronic subclinical mastitis during lactation in modern dairy farms. Israel Journal of Veterinary Medicine 67 162–169 Merin U, Fleminger G, Komanovsky J, Silanikove N, Bernstein S & Leitner G 2008 Subclinical udder infection with Streptococcus dysgalactiae impairs milk coagulation properties: the emerging role of proteose peptones. Dairy Science and Technology 88 407–419 Oftedal OT 1984 Milk composition, milk yield and energy output at peak lactation: a comparative review. Symposia of the Zoological Society of London 51 33–85 Politis I 1996 Plasminogen activator system: implications for mammary cell growth and involution. Journal of Dairy Science 79 1097–1107 Shamay A, Shapiro F, Mabjeesh SJ & Silanikove N 2002 Casein-derived phosphopeptides disrupt tight junction integrity, and precipitously dry up milk secretion in goats. Life Sciences 70 2707–2719 Shamay A, Shapiro F, Leitner G & Silanikove N 2003 Infusions of casein hydrolyzates into the mammary gland disrupt tight junction integrity and induce involution in cows. Journal of Dairy Science 86 1250–1258 Shamay A, Homans R, Fuerman Y, Levin I, Barash H, Silanikove N & Mabjeesh SJ 2004 Expression of albumin in nonhepatic tissues and its synthesis by the Bbovine mammary gland. Journal of Dairy Science 88 569–576 Silanikove N 2000 Effects of heat stress on the welfare of extensively managed domestic ruminants. Livestock Production Science 67 1–18
Silanikove N, Shamay A, Shinder D & Moran A 2000 Stress down regulates milk yield in cows by plasmin induced β-casein product that blocks K+ channels on the apical membranes. Life Sciences 67 2201–2212 Silanikove N & Shapiro F 2007 Distribution of xanthine oxidase and xanthine dehydrogenase activity in bovine milk: physiological and technological implications. International Dairy Journal 17 1188–1194 Silanikove N, Iscovich J & Leitner G 2005a Therapeutic treatment with casein hydrolyzate eradicates effectively bacterial infection in treated mammary quarters in cows. In Mastitis in Dairy Production: Current Knowledge and Future Solutions, pp. 327–332 (Ed. H Hogeveen). Wageningen, The Netherlands: Wageningen Academic Publishers Silanikove N, Shapiro F, Shamay A & Leitner G 2005b Role of xanthine oxidase, lactoperoxidase, and NO in the innate immune system of mammary secretion during active involution in dairy cows: manipulation with casein hydrolyzates. Free Radical Biology and Medicine 38 1139–1151 Silanikove N, Merin U & Leitner G 2006 Physiological role of indigenous milk enzymes: an overview of an evolving picture. International Dairy Journal 16 535–545 Silanikove N, Shapiro F & Leitner G 2007 Posttranslational ruling of xanthine oxidase activity in bovine milk by its substrates. Biochemical and Biophysical Research Communications 363 561–565 Silanikove N, Shapiro F & Shinder D 2009 Acute heat stress brings down milk secretion in dairy cows by up-regulating the activity of the milk-borne negative feedback regulatory system. BMC physiology 9 13 Sorrell AM, Shand JH, Tonner E, Gamberoni M, Accorsi J, Beattie PA, Allan GJ & Flint DJ 2006 Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin. Journal of Biological Chemistry 281 10883–10889 Theodorou G, Bizelis L, Rogdakis E & Politis I 2009 The ovine urokinase plasminogen activator and its receptor cDNAs: molecular cloning, characterization and expression in various tissues. Gene 443 158–169 Tonner E, Allan GJ & Flint DJ 2000 Hormonal control of plasmin and tissuetype plasminogen activator activity in rat milk during involution of the mammary gland. Journal of Endocrinology 167 265–273 Weng MH, Chang CJ, Chen WY, Chou WK, Peh HC, Huang MC, Chen MT & Nagahata H 2006 Contribution of somatic cell-associated activation of plasminogen to caseinolysis within the goat mammary gland. Journal of Dairy Science 89 2025–2037 White JH, Zavizion B, O’Harea K, Gilmore I, Guoa MR, Kindstedt P & Politis I 1995 Distribution of plasminogen activator in different fractions of bovine milk. Journal of Dairy Research 62 115–122 Wilde CJ & Peaker M 1990 Autocrine control in milk secretion. Journal of Agricultural Science 114 235–238 Zavizion B, Heegard CW, White J, Cheli F & Politis I 1996 Synthesis of plasminogen activator inhibitor 1 by bovine mammary epithelial and myoepithelial cell lines. Journal of Dairy Research 63 451–458
